Sustained virological response to ombitasvir/paritaprevir/ritonavir and dasabuvir treatment for hepatitis C: Real-world data from a large healthcare provider

2017 ◽  
Vol 25 (2) ◽  
pp. 144-151 ◽  
Author(s):  
C. Weil ◽  
D. Mehta ◽  
G. Koren ◽  
B. Pinsky ◽  
J. C. Samp ◽  
...  
Keyword(s):  
Hepatitis C ◽  
Healthcare Provider ◽  
Sustained Virological Response ◽  
Real World ◽  
Virological Response ◽  
Real World Data ◽  
World Data

scholarly journals Cost and Effectiveness of the Treatment of Chronic Hepatitis C in Brazil: Real-World Data

2020 ◽  
Vol 23 ◽  
pp. 49-54
Author(s):  
Karin Hepp Schwambach ◽  
Mareni Rocha Farias ◽  
Giácomo Balbinotto Neto ◽  
Carine Raquel Blatt
Keyword(s):  
Chronic Hepatitis ◽  
Hepatitis C ◽  
Chronic Hepatitis C ◽  
Real World ◽  
Real World Data ◽  
World Data

scholarly journals Hepatitis C Virus Treatment Response to Ledipasvir/Sofosbuvir Among Patients Co-Infected with HIV and HCV: Real-world Data in a Black Population

2017 ◽  
Vol 4 (suppl_1) ◽  
pp. S659-S659
Author(s):  
Jaspreet Banga ◽  
Sobia Nizami ◽  
Jihad Slim ◽  
Sandhya Nagarakanti ◽  
Mario Portilla ◽  
...  
Keyword(s):  
Hepatitis C Virus ◽  
Hepatitis C ◽  
Treatment Response ◽  
Real World ◽  
Black Population ◽  
Real World Data ◽  
World Data

scholarly journals Public–Private Partnership: Targeting Real-World Data for Hepatitis C Direct-Acting Antivirals

2017 ◽  
Vol 153 (3) ◽  
pp. 626-631 ◽  
Author(s):  
Poonam Mishra ◽  
Jeffry Florian ◽  
Joy Peter ◽  
Monika Vainorius ◽  
Michael W. Fried ◽  
...  
Keyword(s):  
Hepatitis C ◽  
Real World ◽  
Public Private Partnership ◽  
Direct Acting Antivirals ◽  
Real World Data ◽  
Private Partnership ◽  
World Data ◽  
Direct Acting
Sign in / Sign up

Export Citation Format

Share Document